Podlesny, Erin Eileen Title: Synthesis of Bisanthraquinone ... › gms › files › 2015 › 12 ›...

PI: Podlesny, Erin Eileen Title: Synthesis of Bisanthraquinone Natural Product and BINOL-type Chiral

Ligands

Received: 08/11/2009 FOA: PA09-209 Council: 01/2010

Competition ID: ADOBE-FORMS-A FOA Title: Ruth L. Kirschstein National Research Service Awards for Individual

Predoctoral Fellowships (F31) to Promote Diversity in Health-Related Research

1 F31 GM093515-01 Dual: AT,CA,DK,MH Accession Number: 3220080

IPF: 6463801 Organization: UNIVERSITY OF PENNSYLVANIA

Former Number: Department: Chemistry

IRG/SRG: ZRG1 IMST-D (29)L AIDS: N Expedited: N

Subtotal Direct Costs

(excludes consortium F&A)

Animals: N

Humans: N

Clinical Trial: N

Current HS Code: 10

HESC: N

New Investigator: N

Early Stage Investigator: N

Senior/Key Personnel: Organization: Role Category:

Marisa Kozlowski University of Pennsylvania Other (Specify)-Sponsor

Erin Podlesny University of Pennsylvania PD/PI

Reference Letters

hallmo

Typewritten Text

This PDF is not fully Section 508-conformant and has been redacted. This may impact use of screen readers or other assistive technology programs. If assistance is needed, please contact [email protected].

mailto:[email protected]

State Application Identifier

Applicant Identifier

1. * TYPE OF SUBMISSION

4. Federal Identifier

5. APPLICANT INFORMATION * Organizational DUNS:* Legal Name:

Department: Division:

* Street1:

Street2:

* City:

* State:

* ZIP / Postal Code:* Country:

Person to be contacted on matters involving this application* First Name: Middle Name:

* Last Name: Suffix:

* Phone Number: Fax Number:

Email:

6. * EMPLOYER IDENTIFICATION (EIN) or (TIN):

7. * TYPE OF APPLICANT:

Other (Specify):

Women Owned Socially and Economically DisadvantagedSmall Business Organization Type

If Revision, mark appropriate box(es).

9. * NAME OF FEDERAL AGENCY:

A. Increase Award B. Decrease Award C. Increase Duration D. Decrease Duration

E. Other (specify):

10. CATALOG OF FEDERAL DOMESTIC ASSISTANCE NUMBER:

* Is this application being submitted to other agencies?

TITLE:

11. * DESCRIPTIVE TITLE OF APPLICANT'S PROJECT:

12. * AREAS AFFECTED BY PROJECT (cities, counties, states, etc.) 13. PROPOSED PROJECT: 14. CONGRESSIONAL DISTRICTS OF:* Start Date * Ending Date a. * Applicant b. * Project

15. PROJECT DIRECTOR/PRINCIPAL INVESTIGATOR CONTACT INFORMATION* First Name: Middle Name:


Position/Title:

* Organization Name:


* Street1:

Street2:

* City:



* Email:

2. DATE SUBMITTED

3. DATE RECEIVED BY STATE

APPLICATION FOR FEDERAL ASSISTANCE

SF 424 (R&R)

County:

* State:

County:

OMB Number: 4040-0001 Expiration Date: 04/30/2008

Province:

Province:

Prefix:

What other Agencies?

Prefix:

Pre-application Application Changed/Corrected Application

08/11/2009

University of Pennsylvania

Chemistry

19104-6205

Pamela

Caudill

Synthesis of Bisanthraquinone Natural Product and BINOL-type Chiral Ligands

N/A01/01/2010 12/31/2012 PA-002 PA-002

Podlesny

Erin

Chemistry

Graduate Student


Yes No

USA: UNITED STATES

PA: Pennsylvania

USA: UNITED STATES

O: Private Institution of Higher Education

National Institutes of Health

New Resubmission

Renewal Continuation Revision

8. * TYPE OF APPLICATION:

APPLICATION FOR FEDERAL ASSISTANCESF 424 (R&R) Page 216. ESTIMATED PROJECT FUNDING 17. * IS APPLICATION SUBJECT TO REVIEW BY STATE EXECUTIVE

ORDER 12372 PROCESS?

a. YESa. * Total Estimated Project Funding

18. By signing this application, I certify (1) to the statements contained in the list of certifications* and (2) that the statements herein are true, complete and accurate to the best of my knowledge. I also provide the required assurances * and agree to comply with any resulting terms if I accept an award. I am aware that any false, fictitious, or fraudulent statements or claims may subject me to criminal, civil, or administrative penalties. (U.S. Code, Title 18, Section 1001)

19. Authorized Representative

* First Name: Middle Name:


* Position/Title:

* Organization:


* Street1:

Street2:

* City:

* State:



* Email:

* Signature of Authorized Representative * Date Signed

20. Pre-application

* The list of certifications and assurances, or an Internet site where you may obtain this list, is contained in the announcement or agency specific instructions.

County:

c. * Estimated Program Income


21. Attach an additional list of Project Congressional Districts if needed.

Province:

b. * Total Federal & Non-Federal Funds

Prefix:

Chemistry

Joseph

Leona

View AttachmentDelete AttachmentAdd Attachment

Add Attachment Delete Attachment View Attachment

USA: UNITED STATES

Associate Director


DATE:

THIS PREAPPLICATION/APPLICATION WAS MADE AVAILABLE TO THE STATE EXECUTIVE ORDER 12372 PROCESS FOR REVIEW ON:

PROGRAM HAS NOT BEEN SELECTED BY STATE FOR REVIEW

PROGRAM IS NOT COVERED BY E.O. 12372; OR

* I agree

b. NO

424 R&R and PHS-398 SpecificTable Of Contents Page Numbers

SF 424 R&R Face Page------------------------------------------------------------------------------------------ 1

Table of Contents--------------------------------------------------------------------------------------------- 3

Performance Sites--------------------------------------------------------------------------------------------- 4

Research & Related Other Project Information------------------------------------------------------------------ 5

Project Summary/Abstract (Description)---------------------------------------- 6

Public Health Relevance Statement (Narrative attachment)---------------------------------------- 7

Bibliography & References Cited---------------------------------------- 8

Facilities & Other Resources---------------------------------------- 10

Equipment---------------------------------------- 11

Other Attachments---------------------------------------- 12

Diversityeligibilityltr---------------------------------------- 12

Refereelist---------------------------------------- 13

Sponsorplan---------------------------------------- 14

Research & Related Senior/Key Person-------------------------------------------------------------------------- 19

Biographical Sketches for each listed Senior/Key Person---------------------------------------- 20

PHS Fellowship Supplemental Form------------------------------------------------------------------------------ 26

Specific Aims---------------------------------------- 29

Background and Significance---------------------------------------- 30

Preliminary Studies/Progress Report---------------------------------------- 33

Research Design and Methods---------------------------------------- 35

Respective Contributions---------------------------------------- 39

Selection of Sponsor and Institution---------------------------------------- 40

Responsible Conduct and Research---------------------------------------- 41

Goals for Fellowship Training and Career---------------------------------------- 42

Activities Planned under this Award---------------------------------------- 43

Doctoral Dissertation and Other Research Experience---------------------------------------- 44

Table of Contents Page 3

Principal Investigator/Program Director (Last, first, middle): Podlesny, Erin

County:


* State:

* City:

Street2:

Organization Name:

RESEARCH & RELATED Project/Performance Site Location(s)Project/Performance Site Primary Location

* Street1:

Province:


USA: UNITED STATES

* Country:

* City:

* State:

* ZIP / Postal Code:

* Street1:

Street2:

County:

Province:

Organization Name:Project/Performance Site Location

USA: UNITED STATES

1

Additional Location(s)



Performance Sites Page 4


1

1. * Are Human Subjects Involved?

IRB Approval Date:

Human Subject Assurance Number:

2. * Are Vertebrate Animals Used?

IACUC Approval Date:

Animal Welfare Assurance Number

4.b. If yes, please explain:

4.c. If this project has an actual or potential impact on the environment, has an exemption been authorized or an environmental assessment (EA) or environmental impact statement (EIS) been performed?

4.d. If yes, please explain:

5.a. * Does this project involve activities outside the U.S. or partnership with International Collaborators?

5.c. Optional Explanation:

6. * Project Summary/Abstract

10. Equipment

7. * Project Narrative

11. Other Attachments

RESEARCH & RELATED Other Project Information

Exemption Number:

Is the IACUC review Pending?


1.a If YES to Human Subjects

Is the IRB review Pending?

2.a. If YES to Vertebrate Animals

3. * Is proprietary/privileged information included in the application?

4.a. * Does this project have an actual or potential impact on the environment?

5.b. If yes, identify countries:

2 3 4 5 6

8. Bibliography & References Cited

9. Facilities & Other Resources

Close Form Print Page About

Yes No

Yes No

Yes No

Yes No

Yes No

Yes No

Yes No

Yes No

View AttachmentDelete AttachmentProjectSummaryAbstract .pdf Add Attachment

View AttachmentDelete AttachmentAdd Attachmentprojectnarrative.pdf

View AttachmentDelete AttachmentAdd AttachmentReferencesCited.pdf

View AttachmentDelete AttachmentAdd AttachmentFacilities.pdf

View AttachmentDelete AttachmentAdd AttachmentEquipment.pdf

View AttachmentsDelete AttachmentsAdd Attachments

Other Information Page 5


Project Summary/Abstract

Synthesis of Chiral Bisnaphthoquinones and Bisanthraquinones: Natural Product Synthesis and Utility in Asymmetric Catalysis

This project will result in total synthesis of a group of axially chiral bisanthraquinone natural products

that has not been synthesized previously, providing material for biological study. The reported biological activity and physical properties of some of these compounds affects a variety of public health issues including treatment of cancer (suppression of tumor cell growth),7 diabetes,8 hepatitis,9 and depression.10 Also, antioxidant properties have been reported, which may have potential in protecting skin against the effects of UV radiation.12 Still, a great deal of information is lacking for the activity of many of these bisanthraquinones, citing a need for more biological studies. An efficient synthesis of these molecules is central to achieving these goals. Specifically, the generation of the compounds will be achieved via a concerted synthesis that diverges from the same chiral bisnaphthoquinone intermediate (1a). This versatile bisnapththoquinone intermediate will be synthesized from a 2-naphthol via an enatioselective oxidative biaryl coupling reaction, followed by oxidation to 1. Tandem Diels-Alder/aromatization reactions between 1a and various vinyl ketene acetals (2) will provide the bisanthraquinone structure and subsequent transformations will afford natural products (3-7).

In addition, a new class of BINOL-type chiral ligands (8a-b) will be generated from a simpler bisnaphthoquinone precursor (1b). The synthesis of these ligands is important because they could positively impact asymmetric catalysis. Catalytic asymmetric synthesis is important to scientific research because it provides an important means of structural control in synthesis. The synthesis of a specific enantiomer or diastereomer is important in both pharmaceutical and materials chemistry because enantiomers of a particular therapeutic agent may have dissimilar biological activity or materials may have different properties. Following analysis of the stability of these molecules via NMR and HPLC, assessment of their effectiveness in asymmetric catalysis will be explored. Specifically these BINOL analogs will be compared to BINOL, H8-BINOL, perfluoro-BINOL and other electron deficient BINOLs via comparison of yield and enantiomeric excess in a variety of known reactions. Other more hindered derivatives (extended from the quinone moiety) will also be synthesized and analyzed.

3 R1 = Me, R2 = R3 = H skyrin

4 R1 = OMe, R2 = R3 = H bislunatin

5 R1 = R2 = R3 = Me trachypone

6 R1 = OMe, R2 = Me, R3= H

7 R1 = R2 = R3 = H

OR3

OR3

OH

OH

R1

R1

OH

OH

R2

R2

O

OO

O

CO2Me

OMe

O

CO2Me

OMe

O

O

O

R

R

R1

OR4

OTMS2 R

OH

O

R

OH

O

O

O

8a R = H b R = Ar

BINOL analogsBisnaphthoquinone natural products

1a R = OMe b R = H

Project Description Page 6


Project Narrative

The synthesis of bisanthraquinone natural products is relevant to public health because their biological activity may impact a variety of health issues, including treatment of cancer, diabetes, hepatitis, depression, and use as an antioxidant. An efficient synthesis of these molecules is central to a complete analysis of their activity. In addition, a new class of chiral BINOL analogs may positively impact asymmetric catalysis, which is an important method in pharmaceutical chemistry and development of therapeutic agents for treatment of disease.

Public Health Relevance Statement Page 7


Bibliography and References Cited (1) Brunel, J. M. "BINOL: A Versatile Chiral Reagent" Chem. Rev. 2005, 105, 857-897. (2) Nunez Montoya, S. C.; Agnese, A. M.; Cabrera, J. L. "Anthraquinone Derivatives from Heterophyllaea

Pustulata" J. Nat. Prod. 2006, 69, 801-803. (3) Howard, B. H.; Raistrick, H. "Studies in the Biochemistry of Micro-Organisms" Biochem. J. 1954, 56,

56-65. (4) Agusta, A.; Ohashi, K.; Shibuya, H. "Bisanthraquinone Metabolites Produced by the Endophytic

Fungus Diaporthe Sp." Chem. Pharm. Bull. 2006, 54, 579. (5) Delle Monache, F. D.; D'Alouquerque, I. L.; Chiappeta, A. D.; De Mello, J. F. "A Bianthraquinone and

4'-O-Methyl-Ent-Gallocatechin from Cassia Trachypus" Phytochemistry 1992, 31, 259. (6) Singh, V.; Singh, J.; Sharma, J. P. "Anthraquinones from Heartwood of Cassia Siamea" 1992, 31,

2176-2177. (7) Lin, L. C.; Chou, C. J.; Kuo, Y. C. "Cytotoxic Principles from Ventilago Leiocarpa" J. Nat. Prod. 2001,

64, 674-676. (8) Parker, J. C.; McPherson, R. K.; Andrews, K. M.; Levy, C. B.; Dubins, J. S.; Chin, J. E.; Perry, P. V.;

Hulin, B.; Perry, D. A.; Inagaki, T.; Dekker, K. A.; Tachikawa, K.; Sugie, Y.; Treadway, J. L. "Effects of Skyrin, a Receptor-Selective Glucagon Antagonist, in Rat and Human Hepatocytes" 2000, 49, 2079-2086.

(9) Don, M. J.; Huang, Y. J.; Huang, R. L.; Lin, Y. L. "New Phenolic Principles from Hypericum Sampsonii" Chem. Pharm. Bull. 2004, 52, 866-869. (10) Wirz, A.; Simmen, U.; Heilmann, J.; Calis, I.; Meier, B.; Sticher, O. "Bisanthraquinone Glycosides of Hypericum Perforatum with Binding Inhibition to CRH-1 Receptors" Phytochemistry 2000, 55, 941-947. (11) Comini, L. R.; Nunez Montoya, S. C.; Sarmiento, M.; Cabrera, J. L.; Arguello, G. A. "Characterizing

some Photophysical, Photochemical and Photobiological Properties of Photosensitizing Anthraquinones" J. Photochem, Photobiol. A: Chem. 2007, 188, 185-191.

(12) Vargas, F.; Rivas, C.; Zoltan, T.; Lopez, V.; Ortega, J.; Izzo, C.; Pineda, M.; Medina, J.; Medina, E.; Rosales, L. "Antioxidant and Scavenging Activity of Skyrin on Free Radical and some Reactive Oxygen Species" Avances en Quimica 2008, 3, 7-14.

(13) McCaughan, J. S., Jr. "Photodynamic Therapy: A Review" Drugs & Aging 1999, 15, 49-68. (14) Franck, B.; Chahin, R.; Eckert, H.; Langenberg, R.; Radtke, V. "Biomimetic Synthesis of Skyrin"

Angew. Chem. Int. Ed. 1975, 14, 819-820. (15) Tanaka, O.; Kaneko, C. "Metabolic Products of Fungi VI. the Structure of Skyrin. Synthesis of B,B'-

Dimethyl Ether" Pharmaceutical bulletin 1955, 3, 284-286. (16) Savard, J.; Brassard, P. "Reactions of Ketene Acetals-14 the use of Simple Mixed Vinylketene Acetals

in the Annulation of Quinones" Tetrahedron 1984, 40, 3455-3464. (17) Danishefsky, S.; Kitaharai, T. "Useful Diene for the Diels-Alder Reaction" J. Am. Chem. Soc. 1974, 96,

7807-7808. (18) Li, X.; Yang, J.; Kozlowski, M. C. "Enantioselective Oxidative Biaryl Coupling Reactions Catalyzed by

1,5-Diazadecalin Metal Catalysts" Org. Lett. 2001, 3, 1137-1140. (19) Mulrooney, C.; Li, X.; DiVirgilio, E. S.; Kozlowski, M. C. "General Approach for the Synthesis of Chiral

Perylenequinones Via Catalytic Enantioselective Oxidative Biaryl Coupling" J. Am. Chem. Soc. 2003, 125, 6856-6857.

(20) Yao, W.; Wang, J. "Direct Catalytic Asymmetric Aldol-Type Reaction of Aldehydes with Ethyl Diazoacetate" Org. Lett. 2003, 5, 1527-1530.

(21) Hashimoto, T.; Maruoka , K. "6,6ʼ-Substituent Effect of BINOL in Bis-Titanium Chiral Lewis Acid Catalyzed 1,3-Dipolar Cycloaddition of Nitrones" Org. Biomol. Chem. 2008, 6, 2263-2265.

(22) Lou, S.; Moquist, P. N.; Schaus, S. E. "Asymmetric Allylboration of Ketones Catalyzed by Chiral Diols" J. Am. Chem. Soc. 2006, 128, 12660-12661.

(23) Anderson, K. W.; Ikawa, T.; Tundel, R. E.; Buchwald, S. L. "The Selective Reaction of Aryl Halides with KOH: Synthesis of Phenols, Aromatic Ethers, and Benzofurans" J. Am. Chem. Soc. 2006, 128, 10694-10695.

References Cited Page 8


(24) Burgos, C. H.; Barder, T. E.; Huang, X.; Buchwald, S. L. "Significantly Improved Method for the Pd-Catalyzed Coupling of Phenols with Aryl Halides: Understanding Ligand Effects" Angew. Chem. Int. Ed. 2006, 45, 4321–4326.

References Cited Page 9


Facilities and Other Resources: Room 4002 of the Vagelos Laboratory serves as the office of the principal investigator. The principal investigator’s laboratory consists of 3 four-person laboratories (10 hoods) in the Vagelos Laboratory outfitted with standard organic laboratory glassware, vacuum systems, etc., an instrument room, and a computer room. A computer controlled Agilent HP-6850 GC with 8-turret autosampler and a computer controlled Agilent HP HPLC with autosampler capable of analytical separations. A 12 year old double station Vacuum Atmospheres He-453 Glove Box is also present. Within the research group, three computers are dedicated to theoretical calculations: a SGI Octane (Unix, R10,000) and two Pentium IV PCs (WinXP Pro, 1GB, 300GB-HD). Available software includes MacroModel, Chem3D, ViewerPro, Spartan, DivCon, Jaguar, Gaussian98, GaussView, FUNMAP, CAVEAT, QM-QSAR, G-QSAR, and MAPLE as well as a variety of standard commercial math libraries (IMSL, NAG, NR), databases, and compilers to support our program development efforts. For more time consuming calculations (HF, B3LYP, MP2, large QSAR runs, etc.) two additional resources are available: (1) University of Pennsylvania Chemistry Department Computer Facility with several SGI machines including a 4 processor SGI Origin 200; (2) a 64 node with 2 CPU/node Beowulf Linux Cluster in the Department of Chemistry at the University of Pennsylvania (purchased with a multi-PI NSF CRIF grant).

Facilities Page 10


Equipment:

The central spectroscopic facilities of the Chemistry Department are available for this project. Mass spectral facilities: two high resolution spectrometers (VG 70/70 Micromass capable of ESI or CI), a walk-on Micromass Platform LC/MS in low resolution electrospray mode, and a walk-on Agilent GC/MS. NMR facilities: 9 Bruker Fourier transform NMR spectrometers (one 200-MHz, one 250-MHz, one 300-MHz, one 360-MHz, four 500-MHz, one 600-MHz) and three dedicated SGI (O2 or IRIX) work stations for advanced processing. X-ray facility: Rigaku Mercury CCD area detector system equipped with X-stream 2000 low temperature device. Software includes Rigaku/MSC CrystalClear package for area detector data processing and Rigaku/MSC CrystalStructure package for structure solution and refinement.

Other research groups in the department have provided the part-time use of a

Perkin-Elmer FTIR (G. Molander), a UV/Vis spectrophotometer (F. Gai), a Perkin-Elmer polarimeter (G. Molander), and a Kugelrohr distillation apparatus (J. Winkler).

Equipment Page 11


Department of Chemistry Marisa C. Kozlowski, Ph. D. Roy and Diana Vagelos Laboratories Professor

231 South 34th Street Philadelphia, PA 19104-6323

Leona Joseph

Associate Director

Office of Research Services


[email protected]

215-898-9984

August 13, 2009

To Whom It May Concern:

Please accept this letter as certification of eligibility for the Applicant Fellow, Erin Podlesny, for the

Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships (F31) to Promote

Diversity in Health-Related Research (PA-09-209).

.

Should you have any questions or concerns regarding this applicant, please feel free to contact me. We

thank you for your time and attention.

Sincerely,

Marisa C. Kozlowski

Diversityeligibilityltr Page 12


List of Referees

t Page 13


Section II--Sponsor and Co-Sponsor Information: 1. Research Support Available

KOZLOWSKI, M. C. ADC = annual direct costs ATC = annual total costs TDC = total direct costs (provided for instrumentation grants) TC = total costs (provided for instrumentation grants) ACTIVE GOALI (Molander) 5/1/09 – 4/30/12 1.00 calendar NSF $397,957(ADC) [MCK $40,000 ADC] $500,000 (ATC) [MCK $56,800 ATC] “High Throughput Experimentation for Reaction Optimization” In collaboration with Merck, the use of high throughput experimentation and design of experiment principles will be examined in range of new reaction methods. R56 CA109164 (Kozlowski) 7/1/09 – 6/30/10 1.50 calendar NIH/NCI - ARRA $131,845 (ADC), $196,173 (ATC) "Synthesis of Novel Anticancer Agents” Perylenequinone natural products and analogs will be synthesized and examined as anticancer photodynamic therapeutics. CHE-0911713 (PI Kozlowski) 9/1/09 - 8/31/12 1.00 calendar National Science Foundation $102,724 (ADC), $150,000 (ATC) “Oxidative Methods for C-C and C-N Bond Formation” New oxidative processes targeted for development include: phenol couplings, bisnaphthoquinone and bisanthraquinone syntheses, and N-arylation reactions. 47616-AC1 (Kozlowski) 1/1/08 – 8/30/10 0.50 calendar

CHE-0616885 (Kozlowski) 9/1/06 - 8/31/09 1.00 calendar National Science Foundation $94,072 (ADC), $139,000 (ATC) “Oxidative Methods for C-C and C-N Bond Formation” This study focuses on the mechanism of Cu catalyzed oxidative naphthol couplings and related oxidative reactions..

Sponsorplan Page 14


CHE-0840438 (Lester) 2/1/09 – 1/31/12 0.10 calendar NSF/CRIF $226,854 (TDC), $226,854 (TC) “Purchase of an X-Ray Diffractometer” Purchase of a departmental X-ray diffractometer to replace an aging instrument. S10RR022442 (Smith) 9/30/06 – 9/29/08 0.10 calendar NIH/NCRR $500,000 (TDC), $500,000 (TC) “NMR systems: 2 Bruker Avance 500 Consoles” Update of outdated user interfaces for NMR spectrometers critical for chemistry synthesis research.

2. Sponsor's/Co-Sponsor’s Previous Fellows/Trainees

Total previous predoctoral: 18 Total previous postdoctoral: 13 Representative trainees: Erin DiMauro, predoctoral, B.A. Wesleyan Univ., Amgen, Research Scientist Stephen Waters, predoctoral, B.S. Univ. Pittsburgh, postdoctoral with Sam Danishefsky

at Sloan-Kettering, University of Vermont, Assistant Professor V. Annamalai, predoctoral, B.S. Georgia Inst. Technology, postdoctoral with Laura

Kiessling at Univ. Wisconsin

Sponsorplan Page 15


Michael Fennie, predoctoral, B.S. Canisus College, Sanofi-Aventis, Research Scientist Barbara Jane Morgan, predoctoral, B.S. Kenyon College, postdoctoral at the Broad

Institute Bishwajit Ganguly, postdoctoral, Ph.D. Inst. of Science Bangalore, Central Salt and

Marine Chemical Research Inst. India, Scientist E-1

3. Training Plan, Environment, Research Facilities i) Ph.D. Candidacy Requirements: Ms. Podlesney has completed all the

requirements for PhD candidacy at Penn including coursework, cumulative exams, and two semesters of teaching. Coursework consisted of organic chemistry mechanisms, organic synthesis, organometallic chemistry, heterocyclic chemistry, bioorganic chemistry, physical organic chemistry, organic materials chemistry, and chemistry literature/database searching.

ii) Meetings and Interactions: Joint group meetings between the Walsh (Organometallic Chemistry) and Kozlowski (Organic and Bioorganic Chemistry) groups are held weekly. After analyzing problems from the literature, one group member provides a formal presentation of their research from the last 6-9 months. Group discussion following the presentation provides a critique into the approaches taken and suggestions for further study. In conjunction, a written report is required, detailing the research from this time period. The reports are written in thesis format at a level of writing that would be appropriate for publication. Reports of this nature allow improvement of writing skills, self-evaluation of progress in the lab, and maintenance of satisfactory experimental records.

In addition, weekly Kozlowski group meetings will take place to review progress in the laboratory, troubleshoot problems, and identify new directions. As the total synthesis work draws to close, more time will be devoted to identifying the biological target(s) by meeting with collaborators in the Penn Medical School to develop further experiments. As the work on the chiral bisnaphthoquinones ramps up, opportunities for their use in materials chemistry will be explored via meetings with collaborators in Chemistry and the Laboratory for Research on the Structure of Matter (So-Jung Park, Andrew Feiring, Cheri Kagan).

iii) Seminars and Conferences: The University of Pennsylvania is at the hub of a vibrant region for science and research presenting an excellent environment for scientific discourse and numerous opportunities for continuing professional development. The Department of Chemistry alone maintains weekly seminar programs in four areas: Organic, Biological, Physical, and Inorganic Chemistry. In addition to academic speakers, speakers are drawn from local companies: Merck, Glaxo SmithKline, Wyeth, Bristol Myers Squibb, Aventis, Hoffmann LaRoche, etc., providing attendees with an appreciation of current biomedical topics of interest. Named and interdisciplinary lectureships from leaders in the field are held several times during the year. Students are also encouraged to attended seminars in their field outside of the Department Chemistry held at the Medical School, Wistar Institute, Laboratory for Research on the Structure of Matter, etc.

Ms. Podlesny is also a participant in the Chemical Biology Interface (CBI) program between the Department of Chemistry, the Department of Biology, and the Penn Medical School Biomedical Graduate Studies. The goal of the CBI training program is to provide students with the intellectual and technical skills required to solve important and complex biological problems that can be most effectively addressed by studies at the chemistry-biology interface and to create a group of graduating chemists and biologists who can effectively communicate and function successfully in multidisciplinary teams. The focus of the CBI training program will be mechanistic chemistry of proteins, which

Sponsorplan Page 16


is a theme that is of special interest to us with respect to the bisanthraquinone natural products. The CBI program includes coursework, monthly talks, and a twice annual mini-symposium centering on bioorganic chemistry. Even though Ms. Podlesney has completed the coursework required for the Ph.D. degree, she will take further courses in chemical biology, cell biology, and biochemistry to broaden her training and to be able to exploit the utility of her natural products.

Ms. Podlesney will attend national ACS meetings and NOS meetings on an annual basis to provide exposure to the broader scientific community. A further opportunity for professional development will be attendance of a Gordon Research Conference relative to her research interests in her fourth or fifth year to provide networking and prepare her for career after the Ph.D. degree. Finally, if her research moves into a specialized area (i.e. photodynamic therapy), then she will attend conferences or workshops in that area to gain further background and expertise.

iv) Research Environment and Facilities: The research community at Penn is vibrant. In Chemistry alone, there are ~190 doctoral students, ~70 postdoctoral fellows, and ~10 full-time scientific staff to support the ongoing research efforts. Approximately ~30 Ph.D. students graduate each year leading the School of Arts in Sciences at Penn. These students go on to high-profile postdoctoral, industrial, and academic positions. In addition, opportunities for interaction in the fields of biology and medicine abound with the School of Medicine, the Abramson Cancer Center, the Presbyterian Medical Center, and the Wistar Institute all located within a few blocks of the Chemistry department. For the chiral bisnapthoquinones as organic materials, the strong ties to the Laboratory for Research on the Structure of Matter, Chemical Engineering, Materials Science, and the Penn Regional Nanotechnology Facility are in place.

The research facilities at Penn for this work include the standard facilities in Chemistry as well significant additional resources as conditions warrant from the institutes and centers listed above. The Chemistry facilities undergo constant renewal with recent instrumentation grants having updated the NMR, X-ray, and MS facilities. The Chemistry complex is comprised of four buildings with older facilities being renovated on a rotating basis. Our laboratory space is located in the 11-year old Vagelos Laboratories.

v) Additional Required Training or Technical Skills: Training in departmental instrumentation will continue to be provided by Dr. George Furst (Director, NMR Services), Dr. Rakesh Kohli (Director, MS Services), and Dr. Patrick Carroll (Director, Crystallographic Facility). Under the tutelage of Dr. Steven Johnson (University of Pennsylvania Medical School, Department of Hematology/Oncology), all of the necessary equipment and training for cancer cell assays is available. Should these assays prove encouraging, then Theresa Busch (University of Pennsylvania Medical School, Department of Radiation Oncology) will provide further training and guidance in testing of the photodynamic therapeutic properties of the bisanthraquinone natural products including clonogenic cell assays, animal toxicity studies, and animal tumor model studies. Both these collaborations are firmly established with our ongoing work using the perylenequinone natural products (J. Am. Chem. Soc. 2009, 131, 9413–9425).

vi) Applicant’s Career Goals: With strong interests in organic synthesis and a desire to pursue a career in basic research, an individual development plan will be devised and examined periodically with Ms. Podlesney. The current version combines strong training in the core area of organic synthesis combined with interdisciplinary training in biological chemistry and/or materials science. Regardless of the precise direction the research develops, Ms. Podlesney will emerge with the skills to solve complex chemical problems in a team environment.

Sponsorplan Page 17


4. Number of Fellows/Trainees to be Supervised During the Fellowship Total predoctoral: 8 Total postdoctoral: 2

5. Applicant's Qualifications and Potential for a Research Career Ms. Podlesny received her BS in Chemistry from Gettysburg College.

She was an undergraduate researcher in two laboratories, one at Gettysburg and one at the University of Virginia.

This assessment is in line with her performance here at Penn has gotten off to an impressive start in her first year in the

laboratory. For example, in Amos Smith's total synthesis class she was assigned one of the axially chiral bisanthraquinone synthetic targets that my group was considering (she is now moving forward with this synthesis following one of the plans she designed). For the class, two synthesis proposals were required, one utilizing enantioselective induction and one starting from commercially available chiral materials. While the first synthesis could be devised using our catalytic asymmetric oxidative naphthol coupling, the second was very challenging since axially chiral compounds are not abundant precursors (i.e. available from commercial sources at less than $1 per gram). She came up with a synthesis commencing from BINOL that was both clever and insightful. Prof. Amos Smith, Prof. Patrick Walsh, and I all commented on how innovative her proposal was as we had never seen any synthesis starting from BINOL, which is now relatively inexpensive (~35 cents per gram).

In her one year in my laboratory, Ms. Podlesny has made excellent progress in her project on the bisnapthoquinones and the corresponding bisanthraquinone natural products. she has been the most productive among the four students from her class in my group.

My philosophy toward student training is to provide a preliminary plan with missing details and important concepts. Ms. Podlesny has shown that she can manage such input and she has significantly developed the very preliminary project outline that I gave her. She has identified further natural products, developed completely new synthetic routes, and tackled significant difficulties in implementation of the research plan. Already, she is growing into the role of an interesting and innovative coworker vs a novice student. As she continues to mature, I will challenge her to develop new projects and new ideas based both on her current work and her developing interests via one-on-one meetings as well as group discussions. I find that this method may result in slower research progress initially since I do not lay out every experiment. However, the ultimate result is a well-developed, confident student who can identify important problems and develop plans for experimental implementation fully independently. Activities to foster this development will include writing manuscripts, identifying and researching new projects for younger coworkers and grant applications, supervising undergraduate students and junior graduate students, reviewing important literature topics for the group, and ultimately writing research proposal sections.

At this stage in her development, Ms. Podlesny compares to the best students that have come out of my lab. I am excited to work with her further to complete her development as an independent scientist.

Sponsorplan Page 18


Province:

PROFILE - Project Director/Principal Investigator

Prefix: * First Name: Middle Name:


Organization Name: Division:

Position/Title: Department:

* Street1:

Street2:


* E-Mail:

Credential, e.g., agency login:

* Project Role: Other Project Role Category:

* Zip / Postal Code:* Country:

* State:

County:* City:

Attach Current & Pending Support

RESEARCH & RELATED Senior/Key Person Profile (Expanded)

*Attach Biographical Sketch

Erin

Podlesny

Graduate Student Chemistry


USA: UNITED STATES 19104-6323

PD/PI

View AttachmentDelete AttachmentAdd Attachmentapplicantfellowbiosketch.pdf


Province:

PROFILE - Senior/Key Person

Prefix: * First Name: Middle Name:


Organization Name: Division:

Position/Title: Department:

* Street1:

Street2:


* E-Mail:

Credential, e.g., agency login:

* Project Role: Other Project Role Category:

* Zip / Postal Code:* Country:

* State:

County:* City:

Attach Current & Pending Support

*Attach Biographical Sketch

Professor


Chemistry

USA: UNITED STATES

Marisa

Kozlowski

19104-6323

SponsorOther (Specify)

biosketchKozlowski.pdf Add Attachment Delete Attachment View Attachment


1


ADDITIONAL SENIOR/KEY PERSON PROFILE(S) Add Attachment Delete Attachment View Attachment

Additional Biographical Sketch(es) (Senior/Key Person) Add Attachment Delete Attachment View Attachment

Additional Current and Pending Support(s) Add Attachment Delete Attachment View Attachment

Key Personnel Page 19


FELLOWSHIP APPLICANT BIOGRAPHICAL SKETCH USE ONLY FOR INDIVIDUAL PREDOCTORAL and POSTDOCTORAL FELLOWSHIPS. DO NOT EXCEED FOUR PAGES.

NAME OF FELLOWSHIP APPLICANT Erin E. Podlesny eRA COMMONS USER NAME (credential, e.g., agency login)

POSITION TITLE Predoctoral researcher

EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)

INSTITUTION AND LOCATION DEGREE (if applicable) YEAR(s) FIELD OF STUDY

Gettysburg College B.S. 05/2007 Chemistry; Biology minor University of Pennsylvania Ph.D. 2012 Organic Chemistry

A. Positions and Honors

ACTIVITY/OCCUPATION

BEGINNING DATE

(mm/yy)

ENDING DATE

(mm/yy) FIELD INSTITUTION/COMPANY SUPERVISOR/

EMPLOYER

Academic and Professional Honors Presidential Scholarship, Gettysburg College, 2003-2007 CRC Press Freshman Chemistry Achievement Award, Gettysburg College, 2004 Organic Chemistry Achievement Award, Gettysburg College, 2005 NSF REU Chemistry Fellowship, University of Virginia, 2006 ACS Undergraduate Award in Analytical Chemistry, Gettysburg College, 2006 Honorable Mention for NSF Graduate Research Fellowship, 2007 American Chemical Society certification, 2007 Society for Analytical Chemists of Pittsburgh Award, 2007 Stine Chemistry Prize, Gettysburg College, 2007 B.S. awarded with departmental honors, Summa Cum Laude, Valedictorian, 2007 Teaching assistant commendation, Chemistry Department, University of Pennsylvania, 2009 NIH Chemistry-Biology Interface Training Fellowship, 2009 Memberships in professional societies: Phi Beta Kappa Omicron Delta Kappa American Chemical Society B. Publications Abstracts: Podlesny, E. E. and Jameson, D. L. Metallocage coordination complexes from dipyridine ligands possessing a carbazole nucleus. Abstract for Inorganic poster session, American Chemical Society National Meeting, Chicago, IL, March 2007. Reviews:

Biosketches Page 20


C. Scholastic Performance SCIENCE OTHER

YEAR COURSE TITLE GRADE YEAR COURSE TITLE GRADE

GETTYSBURG COLLEGE GETTYSBURG COLLEGE 2003 Intro to Ecology and Evolution 2003 Fundamental Spanish I 2003 Chemical Structure and Bonding 2004 Calculus I 2003 Exploring the World of Fungi 2004 Fundamental Spanish II 2004 Form and Function/Living Organisms 2004 Calculus II 2004 Chemical Reactivity 2004 Intermediate Spanish I 2004 Genetics 2005 Intermediate Spanish II

2004 Organic Chemistry I 2005 Intro to Archaeology and Physical Anthropology

2005 Cell Biology 2006 Gettysburg in History and Memory 2005 Organic Chemistry II 2006 Multivariable Calculus 2005 Chem. Applications of Spectroscopy 2007 Intro to the Civil War Era 2005 Instrumental Analysis 2005 Advanced Organic Chemistry 2005 Introductory Modern Physics I 2006 Advanced Inorganic Chemistry 2006 Introductory Modern Physics II 2006 Developmental Biology 2006 Physical Chemistry I 2006 Biochemistry I 2006 Individualized Study-Research

2006 Individualized Study-Research (summer)

2007 Biochemistry II 2007 Physical Chemistry II 2007 Individualized Study-Research UNIVERSITY OF PENNSYLVANIA 2007 Organic Mechanisms 2007 Organic Reactions 2007 Organometallics 2008 Physical Organic Chemistry 2008 Advanced Organic Synthesis 2008 Topics in Organic Chemistry 2008 Topics in Organic Chemistry 2008 Topics in Organic Chemistry 2008 Topics in Organic Chemistry 2008 Independent Study 2009 Independent Study

Except for the summer individualized study-research course, Gettysburg College courses were graded on a 4.33 scale with plus and minus grades (i.e. A+ is 4.33, A is 4.0). The summer individualized study-research course was graded on a satisfactory (S) or unsatisfactory (U). Satisfactory is a C– or better. Courses at the University of Pennsylvania were graded on a 4.0 scale (A/A+). GRE Scores:

Biosketches Page 21


.

BIOGRAPHICAL SKETCH Provide the following information for the key personnel and other significant contributors.

Follow this format for each person. DO NOT EXCEED FOUR PAGES.

NAME Kozlowski, Marisa C. eRA COMMONS USER NAME

POSITION TITLE Associate Professor, University of Pennsylvania

EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)

INSTITUTION AND LOCATION DEGREE (if applicable) YEAR(s) FIELD OF STUDY

Cornell University, Ithaca, NY BA 1989 Chemistry U.C. Berkeley, Berkeley, CA PhD 1994 Organic Chemistry Harvard University PostDoc 1995-1997 Organic Chemistry

Please refer to the application instructions in order to complete sections A, B, and C of the Biographical Sketch.

A. Research & Professional Experience Research Experience and Employment: PhD Candidate/Research Asst., Mentor – Prof. Paul Bartlett, U. C. Berkeley 1989-1994 NSF Postdoctoral Research Fellow, Mentor – Prof. David A. Evans, Harvard Univ. 1995-1997 Assistant Professor, Chemistry Department, University of Pennsylvania 1997-2003 Associate Professor, Chemistry Department, University of Pennsylvania 2003-2009 Professor, Chemistry Department, University of Pennsylvania 2009- Honors: Cornell Tradition Fellowship, Cornell University 1985-1989 Merck Chemistry Award, Cornell University 1989 Department of Education Fellowship, University of California at Berkeley 1989-1992 Syntex Fellowship, University of California at Berkeley 1992-1993 National Science Foundation Postdoctoral Fellowship, Harvard University 1995-1996 DuPont Young Investigator Award, University of Pennsylvania 1998-2001 National Science Foundation CAREER Award 2001-2006 George Lesher Lecturer in Bioorganic and Medicinal Chemistry (RPI) 2001 Alfred P. Sloan Research Fellow 2002-2004 Kahn Award for Distinguished Teaching by an Assistant Professor 2002 American Cancer Society Beginning Research Scholar 2002-2006 ACS Travel Progress Award 2007

B. Selected Publications (54 of 72 total) 12) Li, X.; Schenkel, L. B.; Kozlowski, M. C. "Synthesis and Resolution of a Novel Chiral Diamine Ligand and

Application to Asymmetric Lithiation-Substitution" Org. Lett. 2000, 2, 875-878. http://dx.doi.org/10.1021/ol9903133

13) Ganguly, B.; Freed, D. A.; Kozlowski, M. C. "Relevance of Torsional Effects to the Conformational Equilibria of 1,5-Diaza-cis-decalins: A Theoretical and Experimental Study" J. Org. Chem. 2001, 66, 1103-1108. http://dx.doi.org/10.1021/jo000580i

14) Li, X.; Yang, J.; Kozlowski, M. C. "Enantioselective Oxidative Biaryl Coupling Reactions Catalyzed by 1,5-Diazadecalin Metal Complexes" Org. Lett. 2001, 3, 1137-1140. http://dx.doi.org/10.1021/ol015595x

16) Waters, S. P.; Kozlowski, M. C. "Synthesis of the Isocoumarin Portion of the Rubromycins" Tetrahedron Lett. 2001, 42, 3567-3570. http://dx.doi.org/10.1016/S0040-4039(01)00524-X

18) DiMauro, E. F.; Kozlowski, M. C. "BINOL-Salen Metal Catalysts Incorporating a Bifunctional Design" Org. Lett. 2001, 3, 1641-1644. http://dx.doi.org/10.1021/ol0158213

Biographical Sketches for each listed Senior/Key Person 2 Page 22


.

21) Xie, X; Kozlowski, M. C. "Synthesis of the Naphthalene Portion of the Rubromycins" Org. Lett. 2001, 3, 2661-2663. http://dx.doi.org/10.1021/ol016220e

22) DiMauro, E. F.; Kozlowski, M. C. "Salen-Derived Catalysts Containing Secondary Basic Groups in the Addition of Diethylzinc to Aldehydes" Org. Lett. 2001, 3, 3053-3056. http://dx.doi.org/10.1021/ol016535u

24) DiMauro, E. F.; Kozlowski, M. C. "Late Transition Metal Complexes of BINOL-Derived Salens: Synthesis, Structure, and Reactivity" Organometallics 2002, 21, 1454-1461. http://dx.doi.org/10.1021/om010571f

25) Kozlowski, M. C.; Panda, M. "Computer-Aided Design of Chiral Ligands. Part I. Database Search Methods to Identify Chiral Ligand Types for Asymmetric Reactions" J. Mol. Graphics Modell. 2002, 20, 399-409. http://dx.doi.org/10.1016/S1093-3263(01)00138-3

26) Xu, Z.; Kozlowski, M. C. "Conformational Control of Flexible Molecules: Design and Synthesis of Novel Chiral 1,5-Diaza-cis-decalins" J. Org. Chem. 2002, 67, 3072-3078. http://dx.doi.org/10.1021/jo025503x

28) Phuan, P.-W.; Kozlowski, M. C. "Control of the Conformational Equilibria in Aza-cis-Decalins: Structural Modification, Solvation, and Metal Chelation " J. Org. Chem. 2002, 67, 6339-6346. http://dx.doi.org/10.1021/jo025544t

29) Panda, M.; Phuan, P.-W. Kozlowski, M. C. "Utility of Calculated 13C NMR Chemical Shifts in Differentiating Conformational Isomers: A Study of Metal-Complexed and Uncomplexed Bispidines" J. Chem. Soc., Chem. Commun. 2002, 1552-1553. http://dx.doi.org/10.1039/b201950g

30) Kozlowski, M. C.; Li, X.; Carroll, P. J.; Xu, Z. "Copper(II) Complexes of Novel 1,5-Diaza-cis-decalin Diamine Ligands: An Investigation of Structure and Reactivity" Organometallics 2002, 21, 4513-4522. http://dx.doi.org/10.1021/om020425p

31) DiMauro, E. F.; Kozlowski, M. C. "Development of Bifunctional Salen Catalysts: Rapid, Chemoselective Alkylations of α-Ketoesters" J. Am. Chem. Soc. 2002, 124, 12668-12669. http://dx.doi.org/10.1021/ja026498h

32) DiMauro, E. F.; Kozlowski, M. C. "The First Catalytic Asymmetric Addition of Dialkylzincs to α-Ketoesters" Org. Lett. 2002, 4, 3781-3784. http://dx.doi.org/10.1021/ol026315w

34) Kozlowski, M. C.; Waters, S. P.; Skudlarek, J. W.; Evans, C. A. "Computer-Aided Design of Chiral Ligands. Part III. A Novel Ligand for Asymmetric Allylation Designed Using Computational Techniques" Org. Lett. 2002, 4, 4391-4393. http://dx.doi.org/10.1021/ol026971w

35) Smith, A. B., III.; Lee, D.; Adams, C. M.; Kozlowski, M. C. "SmI2-Promoted Oxidation of Aldehydes in the Presence of Electron Rich Heteroatoms" Org. Lett. 2002, 4, 4539-4541. http://dx.doi.org/10.1021/ol027095p

36) DiMauro, E. F.; Mamai, A.; Kozlowski, M. C. "Synthesis, Characterization, and Metal Complexes of a Salen Ligand Containing a Quinoline Base" Organometallics 2003, 22, 850-855. http://dx.doi.org/10.1021/om0205795

37) Annamalai, V.; DiMauro, E. F.; Carroll, P. J.; Kozlowski, M. C. "Catalysis of the Michael Addition Reaction by Late Transition Metal Complexes of BINOL-Derived Salens" J. Org. Chem. 2003, 68, 1973-1981. http://dx.doi.org/10.1021/jo025993t

38) Kozlowski, M. C.; Panda, M. "Computer-Aided Design of Chiral Ligands. Part II. Functionality Mapping as a Method to Identify Stereocontrol Elements for Asymmetric Reactions" J. Org. Chem. 2003, 68, 2061-2076. Featured on the cover, March 21, 2003 (issue #6). http://dx.doi.org/10.1021/jo020401s

39) Xie, X.; Phuan, P.-W.; Kozlowski, M. C. "Novel Pathways for the Formation of Chiral Binaphthyl Polymers: Oxidative Asymmetric Phenolic Coupling and Tandem Glaser/Oxidative Asymmetric Phenolic Coupling" Angew. Chem., Int. Ed. 2003, 42, 2168-2170. http://dx.doi.org/10.1002/anie.200250325

40) Kozlowski, M. C.; Dixon, S.; Panda, M.; Lauri, G. "Quantum Mechanical Models Correlating Structure with Selectivity: Predicting the Enantioselectivity of β-Amino Alcohol Catalysts in Aldehyde Alkylation" J. Am. Chem. Soc. 2003, 125, 6614-6615. http://dx.doi.org/10.1021/ja0293195

41) Mulrooney, C. A.; Li, X.; DiVirgilio, E. S.; Kozlowski, M. C. "General Approach for the Synthesis of Chiral Perylenequinones via Catalytic Enantioselective Oxidative Biaryl Coupling" J. Am. Chem. Soc. 2003, 125, 6856-6857. http://dx.doi.org/10.1021/ja027745k

42) Li, X.; Hewgley, J. B.; Mulrooney, C.; Yang, J.; Kozlowski, M. C. "Enantioselective Oxidative Biaryl Coupling Reactions Catalyzed by 1,5-Diazadecalin Metal Complexes: Efficient Formation of Chiral Functionalized BINOL Derivatives" J. Org. Chem. 2003, 68, 5500-5511. http://dx.doi.org/10.1021/jo0340206

43) Lipkowitz, K. B.; Kozlowski, M. C. "Understanding Stereoinduction in Catalysis via Computer: New Tools for Asymmetric Synthesis" Synlett 2003, 1547-1565. http://dx.doi.org/10.1055/s-2003-40849



.

44) Phuan, P.-W.; Ianni, J. C.; Kozlowski, M. C. "Is the A-Ring of Sparteine Essential for High Enantioselectivity in the Asymmetric Lithiation-Substiution of N-Boc-pyrrolidine?” J. Am. Chem. Soc. 2004, 126, 15473-15479. http://dx.doi.org/10.1021/ja046321i

45) Fennie, M. W.; DiMauro, E. F.; O’Brien, E. M.; Annamalai, V.; Kozlowski, M. C. “Mechanism and Scope of Salen Bifunctional Catalysts in Asymmetric Aldehyde and α-Ketoester Alkylation” Tetrahedron 2005, 61, 6249-6265; invited contribution to "Catalysis in Industry and Academia" Symposium-in-Print. http://dx.doi.org/10.1016/j.tet.2005.03.117

46) Kozlowski, M. C.; DiVirgilio, E. S.; Malolanarasimhan, K.; Mulrooney, C. A. “Oxidation of Chiral α-Phenylacetate Derivatives: Formation of Dimers with Contiguous Quaternary Stereocenters versus Tertiary Alcohols” Tetrahedron: Asymmetry 2005, 16, 3599–3605; invited contribution to "Asymmetric Oxidations" Symposium-in-Print. http://dx.doi.org/10.1016/j.tetasy.2005.10.008

47) Ianni, J. C.; Annamalai, V.; Phuan, P.-W.; Kozlowski, M. C. “A Priori Theoretical Prediction of Selectivity in Asymmetric Catalysis: Design of New Chiral Catalysts using Quantum Molecular Interaction Fields” Angew. Chem., Int. Ed. 2006, 45, 5502-5505. http://dx.doi.org/10.1002/anie.200600329

48) Huang, J.; Ianni, J. C.; Antoline, J. E.; Hsung, R. P; Kozlowski, M. C. “De Novo Chiral Amino Alcohols in Catalyzing Asymmetric Additions to Aryl Aldehydes” Org. Lett. 2006, 8, 1565-1568. http://dx.doi.org/10.1021/ol061112j

49) Basra, S.; Fennie, M. W.; Kozlowski, M. C. “Catalytic Asymmetric Addition of Dialkylzincs to α-Aldiminoesters” Org. Lett. 2006, 8, 2659-2662. http://dx.doi.org/10.1021/ol0602093

50) Waters, S. P.; Kozlowski, M. C. “Convergent Route to the Purpuromycin Bisphenolic Spiroketal: Hydrogen Bonding Control of Spiroketalization Stereochemistry” Tetrahedron. Lett. 2006, 47, 5409–5413. http://dx.doi.org/10.1016/j.tetlet.2006.05.044

51) Waters, S. P.; Fennie, M. W.; Kozlowski, M. C. “Investigation of a Convergent Route to Purpuromycin: Benzofuran Formation vs Spiroketalization” Org. Lett. 2006, 8, 3243-3246. http://dx.doi.org/10.1021/ol061112j

52) DiVirgilio, E. S.; Dugan, E. C.; Mulrooney, C. A.; Kozlowski, M. C. “Asymmetric Total Synthesis of Nigerone” Org. Lett. 2007, 9, 385-388. http://dx.doi.org/10.1021/ol062468y

53) Kozlowski, M. C., Dugan, E. C.; DiVirgilio, E. S.; Maksimenka, K.; Bringmann, G. “Asymmetric Total Synthesis of Nigerone and ent-Nigerone: Enantioselective Oxidative Biaryl Coupling of Highly Hindered Naphthols” Adv. Synth. Cat. 2007, 349, 583-594; invited contribution to “M. Shibasaki 60th Birthday Dedicated Issue” http://dx.doi.org/10.1002/adsc.200600570

54) Morgan, B. J.; Xie, X.; Phuan, P-W.; Kozlowski, M. C. “Enantioselective Synthesis of Binaphthyl Polymers using Chiral Asymmetric Phenolic Coupling Catalysts: Oxidative Coupling and Tandem Glaser/Oxidative Coupling” J. Org. Chem. 2007, 72, 6171-6182. http://dx.doi.org/10.1021/jo070636+

55) Dickstein, J. S.; Mulrooney, C. A.; O’Brien, E. M.; Morgan; B. J.; Kozlowski, M. C. “Development of a Catalytic Aromatic Decarboxylation Reaction” Org. Lett. 2007, 9, 2441-2444. “Top 20 Most Accessed Articles April-June 2007” http://dx.doi.org/10.1021/ol070749f

56) Lowell, A. N.; Fennie, M. W.; Kozlowski, M. C. “A Concise Synthesis of the Naphthalene Portion of Purpuromycin” J. Org. Chem. 2008, 73, 1911-1918. http://dx.doi.org/10.1021/jo7024114

57) Dickstein, J. S.; Kozlowski, M. C. “Organometal Additions to α-Iminoesters: N-Alkylation via Umpolung” Chem. Soc. Rev. 2008, 37, 1166-1173. http://dx.doi.org/10.1039/b709139g

58) O’Brien, E. M.; Morgan; B. J.; Kozlowski, M. C. “Dynamic Sterochemistry Transfer in a Transannular Aldol Reaction: Total Synthesis of Hypocrellin A” Angew. Chem., Int. Ed. 2008, 47, 6877-6880. http://dx.doi.org/10.1002/anie.200800734 Highlighted in Chemistry World: http://www.rsc.org/chemistryworld/Issues/2008/July/ColumnTotallySynthetic.asp

59) Hewgley, J. B.; Stahl, S. S.; Kozlowski, M. C. “Mechanistic Study of Asymmetric Oxidative Biaryl Coupling: Evidence for Self-Processing of the Copper Catalyst to Achieve Control of Oxidase vs. Oxygenase Activity” J. Am. Chem. Soc. 2008, 130, 12232-12233.http://dx.doi.org/10.1021/ja804570b

60) Joshua S. Dickstein, J. S.; Norman, A.; Fennie, Michael W.; Jennifer, B.; Kozlowski, M. C. “Three Component Coupling of α-Iminoesters via Umpolung Addition of Organometals: Synthesis of α,α-Disubstituted α-Amino Acids” J. Am. Chem. Soc. 2008, 130, 15794–15795. http://dx.doi.org/10.1021/ja8073006

61) Linton, E. C.; Kozlowski, M. C. “Catalytic Enantioselective Meerwein-Eschenmoser Claisen Rearrangement: Asymmetric Synthesis of Allyl Oxindoles” J. Am. Chem. Soc. 2008, 130, 16162–16163. http://dx.doi.org/10.1021/ja807026z

62) Annamali, R.; Linton, E. C.; Kozlowski, M. C. “Design of an Organocatalytic Claisen Rearrangement Catalyst for Monodentate Substrates” Org. Lett. 2009, 11, 621-624. http://dx.doi.org/10.1021/ol8026945



.

63) Wentzel, M. T.; Kamble, R.; Wall, P.; Hewgley, J. B.; Kozlowski, M. C. “Copper Catalyzed N-Arylation of Hindered Substrates Under Mild Conditions” Adv. Synth. Cat. 2009 351, 931-937. http://dx.doi.org/10.1002/adsc.200800730

64) Morgan, B. J.; Dey, S.; Kozlowski, M. C. “Total Synthesis of Cercosporin and New Photodynamic Perylenequinones: Inhibition of the Protein Kinase C Regulatory Domain” J. Am. Chem. Soc. 2009, 131, 9413–9425. http://dx.doi.org/10.1021/ja902324j

Morgan, B. J.; Mulrooney, C. A ki, M. C. “Perylenequinone Natural Products: Evolution of the

70) J , nthesis of the Cores of Hypocrellin and

M. C. one Natural Products:

72) Walsh, P. J.; Kozlowski, M. C. "Fundamentals of Asymmetric Catalysis” University Science Books: 2008.

http://www.uscibooks.com/

C. Research Support ACTIVE: National Institutes of Health (NCI) R56 CA109164 Kozlowski (PI) 8/1/09 - 7/31/10 “Synthesis of Novel Anticancer Agents” Synthesis and anticancer study of the photoactive perylenequinone natural products. National Science Foundation CHE-0616885 Kozlowski (PI) 8/1/06 - 7/31/09 "Oxidative Methods for C-C and C-N Bond Formation" New reactivity in C-C, C-O, and C-N bond formation is explored.

PREVIOUS (last 3 years) NIH/NCI R01 CA109164 Kozlowski (PI) 7/20/04 – 5/30/08 “Synthesis of Novel Anticancer Agents” Synthesis of the bisnaphthopyrone and perylenequinone natural products. NIH/NIGMS R01 GM59945 Kozlowski (PI) 3/1/00 - 2/27/06 "Designing Ligands for Reactions Using Computational Techniques" NSF CAREER Award Kozlowski (PI) 4/1/01 - 3/31/06 "Asymmetric Oxidative Methods for C-C Bond Formation"



PHS Fellowship Supplemental Form

B. Research Training Plan 1. Introduction to Application

(for RESUBMISSION applications only)

2. * Specific Aims

3. * Background and Significance

4. * Preliminary Studies/Progress Report

6. Inclusion Enrollment Report

7. Progress Report Publication List

(for RENEWAL applications only)

(for RENEWAL applications only)

Human Subjects

9. Clinical Trial?

10. Agency-Defined Phase III Clinical Trial?

11. Protection of Human Subjects

12. Inclusion of Women and Minorities

13. Targeted/Planned Enrollment

14. Inclusion of Children

A. Application Type:From SF424 (R&R) Cover Page. The response provided on that page, regarding the type of application being submitted, is repeated here for your reference as you provide the responses that are appropriate for this Fellowship application.

Please note. The following item is taken from the Research & Related Other Project Information form. The response provided on that page, regarding the involvement of human subjects, is repeated here for your reference as you provide related responses for this Fellowship application. If you wish to change the answer to the item shown below, please do so on the Research & Related Other Project Information form; you will not be able to edit the response here.

Are Human Subjects Involved?

8. * Human Subjects Involvement Indefinite?

19. * Respective Contributions

20. * Selection of Sponsor and Institution

21. * Responsible Conduct of Research

Other Research Training Plan Sections

16. Vertebrate Animals

17. Select Agent Research

18. Resource Sharing Plan

Please note. The following item is taken from the Research & Related Other Project Information form. The response provided on that page, regarding the use of vertebrate animals, is repeated here for your reference as you provide related responses for this Fellowship application. If you wish to change the answer to the item shown below, please do so on the Research & Related Other Project Information form; you will not be able to edit the response here.

Are Vertebrate Animals Used?

15. * Vertebrate Animals Use Indefinite?


New Resubmission Renewal Continuation Revision

5. * Research Design and Methods


FinalPlanSpecificAims.pdf Add Attachment Delete Attachment View Attachment

Finalplanbackground.pdf Add Attachment Delete Attachment View Attachment

FinalplanPrelim.pdf Add Attachment Delete Attachment View Attachment

FinalplanMethods.pdf Add Attachment Delete Attachment View Attachment



Yes No

Yes No

Yes No

Yes No

Yes No

Yes No








RespectiveContributions.pdf Add Attachment Delete Attachment View Attachment

SelectionofSponsorandInstitution.p Add Attachment Delete Attachment View Attachment

ResponsibleConductofResearch.pdf Add Attachment Delete Attachment View Attachment

PHS Fellowship Supplemental Form Page 26



C. Additional Information

2. Alternate Phone Number:

3. Graduate Degree Earned (if applicable):

Degree:Date Earned (month/year):

Expected Completion Date (month/year):

8. * Goals for Fellowship Training and Career

9. * Activities Planned Under This Award

7. * Applications for Concurrent Support?

10. Doctoral Dissertation and Other Research Experience

6. * Current Or Prior Kirschstein-NRSA Support?

* Level * Type Start Date (if known) End Date (if known) Grant Number (if known)

If yes, please describe in an attached file:

5. * Field of Training for Current Proposal:

Candidate

11. * Citizenship:

If "other", please indicate degree type:

Degree:

4. Degree Sought During Proposed Award:If "other", please indicate degree type:

If yes, please identify current and prior Kirschstein-NRSA support below:

1. * Does the proposed project involve human embryonic stem cells?

If the proposed project involves human embryonic stem cells, list below the registration number of the specific cell line(s), using the registry information provided within the agency instructions. Or, if a specific stem cell line cannot be referenced at this time, please check the box indicating that one from the Registry will be used:

Specific stem cell line cannot be referenced at this time. One from the registry will be used.

Cell Line(s):

Human Embryonic Stem Cells

Yes No

Reset Entry

PHD : Doctor of Philosophy 12/2012 Reset Entry

1770 Synthetic Chemistry

Yes No

Reset Entry

Reset Entry

Reset Entry

Reset Entry

Yes No

GoalsforFellowshipTrainingandCar

ActivitiesPlannedUnderThisAward.

OtherResearchExperience.pdf

U.S. Citizen or noncitizen national

Permanent Resident of U.S. (If a permanent resident of the U.S., a notarized statement must be provided by the time of award)

Permanent Resident of U.S. Pending

Non-U.S. Citizen with temporary U.S. visa








D. BudgetSenior Fellowship Applicants Only:

a. Federal Stipend Requested:

Amount Academic Period

1. Present Institutional Base Salary:

2. Stipends/Salary During First Year of Proposed Fellowship:

Amount Number of Months

b. Supplementation from other sources:

Amount Number of Months

Type (sabbatical leave, salary, etc.)

Source

Year 1

Year 6 (when applicable)

Year 2

Year 3

Year 4

Year 5

Total Funds Requested:

3. * Tuition and Fees:

C. Additional Information (continued)

* Name of Former Institution:12.

13. Assurances/Certification:

In agreeing to the assurances/certification section 18 on the SF424 (R&R) form, the authorized representative agrees to comply with the policies, assurances and/or certifications listed in the agency's application guide, when applicable. Descriptions of individual assurances/certifications are provided at: http://grants.nih.gov/grants/funding/424.

If unable to certify compliance, where applicable, provide an explanation and attach below.

Explanation:

Institution

Number of Months

All Fellowship Applicants:

E. Appendix

Change of Sponsoring Institution

Reset Entry

None Requested Funds Requested:

16,000.00

16,000.00

16,000.00

48,000.00

Add Attachments Delete Attachments View Attachments




Specific Aims Specific Aim 1: Synthesis and Utility of Chiral Bisnaphthoquinones for Asymmetric Catalysis The synthesis of chiral bisnaphthoquinones 1 will be explored (Scheme 1) with the purpose of generating a set of potentially useful BINOL analogs (2a-2b). These BINOL analogs will then be analyzed in the context of asymmetric catalysis. They will be compared to the parent BINOL ligand, H8-BINOL, perfluoro-BINOL and other electron deficient BINOLs. Scheme 1. BINOL Derivatives.

CO2Me

OMe

O

CO2Me

OMe

O

O

O

1

R

OH

O

R

OH

O

O

O

2a R = H

2b R = Ar Specific Aim 2: Synthesis of Chiral Bisanthraquinone Natural Products Five chiral bisanthraquinone natural products 4-8 will be synthesized via a concerted route from the same bisnaphthoquinone intermediate 3 (Scheme 2). Divergence from this common intermediary will occur via Diels-Alder reactions between the bisnaphthoquinone and various vinyl ketene acetals (10-11), affording the desired bisanthraquinones. The synthesis of the less complex 5,5ʼ-bisoranjidiol 9 will follow a shorter but parallel route, from a simpler bisnaphthoquinone (1, Scheme 1). Scheme 2. Bisanthraquinone Natural Products.




7 R1 = OMe, R2 = Me, R3= H

8 R1 = R2 = R3 = H

9 5,5!-bisoranjidiol

Me

OH O

OH

O

Me

OH O

OH

O

OR3

OR3

OH

OH

R1

R1

OH

OH

R2

R2

O

OO

O

43

2

1

5

6

78

CO2Me

OMe

O

CO2Me

OMe

O

O

O

OMe

OMe

3

R1

OR4

OTMS

OR4

OTMS

Me

11

10

1 OR

OR

Specific Aims Page 29

Specific Aims

Background and Significance Chiral Bisnapthoquinones (Specific Aim 1)

The synthesis of a novel set of chiral bisnaphthoquinones for use as ligands is significant because they have the potential to positively impact asymmetric catalysis. Catalytic asymmetric synthesis is important to scientific research because it provides an important means of structural control in synthesis. The synthesis of a specific enantiomer or diastereomer is important in both pharmaceutical and materials chemistry because enantiomers of a particular therapeutic agent may have dissimilar biological activity or materials may have different properties.

One ligand regularly employed in a variety of enantioselective reactions is the axially chiral ligand BINOL or 1′-bi-2-binaphthol (12, Scheme 3).1 To date many BINOL derivatives have been synthesized, which offer improvements in yield or selectivity over BINOL for many reactions. A majority of these ligands possess a 3,3ʼ-disubstituted scaffold with sterically influential groups at these positions, while another category of BINOL ligands have 6,6ʼ-disubstituted frameworks. The bisnaphthoquinones 1 are not only key intermediates to the bisanthraquinone natural products (see Specifc Aim 2, Scheme 2), but they may also lead to potentially useful BINOL derivatives (2a-2b, 13-14, Scheme 3) for asymmetric catalysis. These novel BINOL analogs would have electron withdrawing groups (para-quinone) and the core bisnaphthoquinone structure would enable facile production of derivatives at the 3,3ʼ- positions or augmentation through the quinone moiety. Scheme 3. Bisnaphthoquinones as BINOL Analogs.

CO2Me

OMe

O

CO2Me

OMe

O

O

O

1

OH

O

OH

O

O

O

OH

O

OH

O

O

O

OH

O

OH

O

O

O

R

R

OH

OH

12 BINOL

36

OH

HO

R

R

OO

O O

O OO O

2a 2b 13 14 Chiral Bisanthraquinones (Specific Aim 2)

The symmetrical bisanthraquinones are a class of biaryl natural products possessing axial chirality (Scheme 2). Members include bisoranjidiol (9),2 skyrin (4),3 bislunatin (5),4 trachypone (6),5 and 7 and 8.6 The biological activity and physical properties that have been reported for some of these compounds encompass a wide spectrum: applications in tumor suppression,7 diabetes,8 hepatitis,9 depression,10 as well as possession of photosensitizing11 and antioxidant properties.12 An efficient synthesis of these molecules is important because it would not only provide significant quantities of all of the bisanthraquinone natural products for biological testing, but also make the synthesis and testing of analogs, or unnatural enantiomers possible.

Bisoranjidiol (9, Scheme 2) is the most recently isolated (2006) of these bisanthraquinones and is notably lacking the hydroxyl at the 4,4ʼ- positions. The dimer is a prominent metabolite found in the leaves of Heterophyllaea pustula (genera Rubiaceae). This is a toxic shrub which grows in the mountains of Argentina and Bolivia.2 Due its phototoxicity, animals eating the shrub tend to suffer from photosensitization, expressed as dermatitis and/or blindness. Bisoranjidiol has been shown to possess photosensitizing properties. Specifically, it can interact with molecular oxygen to produce electronically excited singlet oxygen (1O2) as well as the ground state radical anion (O2•

–).11 Singlet oxygen is a very reactive species which can induce DNA damage and apoptosis of cells. This is the basis of photodynamic therapy (PDT), which is a cancer treatment that uses light to activate a photosensitizing agent to produce reactive oxygen species that cause cell death.13

Skyrin (4, Scheme 2) is the oldest and most studied of these bisanthraquinones. It was first isolated from penicillium islandicum in 19543 and has since been found in a variety of other fungi and lichen. The interest in the molecule stems from its biological activity, as this emodin dimer is reported to suppress the growth of HeLa, Vero, K562, Raji, Wish, and Calu-1 and other tumor cell lines.7 A variety of other biological activities and physical properties have also been observed. For example, skyrin has been reported to interfere with the coupling of glucagon to adenylate cyclase independent of binding to the glucagon receptor. This could be useful for the treatment of diabetes.8 Recently, the antioxidant and radical scavaging ability of skyrin has

Background and Significance Page 30

Background and Significance

also been studied. It was reported that the antioxidant behavior is similar to that of emodin (skyrin monomer) and comparable to vitamin C and E. These properties make skyrin useful, with possible applications in protecting skin against the effects of UV radiation.12

Of the bisanthraquinones in Scheme 2, only prior syntheses of skyrin exist. This biomimetic synthesis of skyrin was achieved by the chemical oxidation of either emodin or emodinanthrone in meger 0.28% and 1.2% yields, respectively.14 Two decades later, a fully methylated derivative was synthesized via an Ullman reaction of the brominated emodin.15 However, there is still much room for improvement as these syntheses are both inefficient and nonstereoselective. To date, no efficient nor asymmetric syntheses of these bisanthraquinones have been achieved. Also, while a variety of biological activities and physical properties have been reported, most of the focus has been on skyrin. The bisanthraquinones are all structurally related and potentially possess similar biological activity and properties. Information of this type is lacking for many of the other bisanthraquinones, citing a need for more biological studies. An efficient synthesis of these molecules is central to achieving these goals. Retrosynthetic Analysis: Bisanthraquinones From a retrosynthetic standpoint there are three key disconnections to form the bisanthraquinones (Scheme 4). In a departure from prior approaches, the anthracenyl ring system will be generated in my work after dimerization. Thus, the first disconnection is the Diels-Alder/aromatization reaction between a bisnaphthoquinone intermediate and the desired vinylketene acetal.16 Alkyl trimethylsilyl- or bis(trimethylsilyl)vinyl ketene acetals, also referred to as Brassard dienes,16 are typically employed though simpler dienes, such as Danishefskyʼs diene,17 have also been used. The bisnaphthoquinone could be formed via oxidation of a 8,8ʼ-dihydroxy bisnaphthol. Finally, an enantioselective biaryl coupling reaction18, 19 leads to the biaryl. Scheme 4. Retrosynthesis.

OR1

OR1

OPG

OPG

CO2Me

CO2Me

O

OO

O

OR1

OR1

OPG

OPG

CO2Me

CO2Me

OHOH

OH

OPG

CO2Me

OPG

OR1

OR1

OH

OH

R3

R3

OH

OH

R2

R2

O

OO

O

R3

OR4

OTMS

R1 = H or Me

R2 = Me or H

R3 = Me, OMe, or H

Diels-Alder and Aromatization

Oxidation Enantioselective Biaryl Coupling

Asymmetric Naphthol Coupling The enantioselective oxidative coupling of naphthols to form the core binaphthol system is a key transformation for the formation of the bisanthraquinones and bisnaphthoquinones (see Scheme 4). This method of oxidative C-C bond formation was developed by the Kozlowski group18, 19 and utilizes a diaza-cis-decalin copper catalyst (15, Scheme 5). This diamine copper catalyst can be used to couple a variety of functionalized 2-naphthols with C3 substitution. The best yields and enantioselectivities were observed with esters or phosphates at C3 (16a-d), attaining up to 85% yield and 93% ee (Scheme 5). Furthermore, highly functionalized substrates could also be coupled (16e-g).



Scheme 5. Enantioselective Oxidative Biaryl Coupling.

CO2Me

CO2Bn

CO2n-Hx

PO(OMe)2

CO2Me

CO2Me

CO2Me

a

b

c

d

e

f

g

H

H

H

H

OAc

OAc

OAc

R1

H

H

H

H

H

H

H

OH

OH

R1

R1R4

R4

R2

R5

R5

R3

R3

R2

1

2

345

6

78R4

R5

R2

R1

OH

R3

(S)10 mol% (R,R)-15

O2

N

NH

H

Cu

OH

I

17

17

H

H

H

H

OMe

OMe

OMe

H

H

H

H

OMe

n-Pr

I

yield (%)

85

79

70

76

72

85

80

ee (%)

91-93

90

87

92

> 90

90

> 85

R2 R3 R4 R5

16



Preliminary Studies Preliminary studies for this proposal have focused on the synthesis of a simple bisnaphthoquinone and investigations into the Diels-Alder reactions needed to form the bisanthraquinones. All preliminary research discussed in this section, except for the initial precedent of enantioselective coupling of 8-substituted 2-naphthols (Scheme 6), was accomplished by myself (fellowship applicant). All of these results are unpublished. Specific Aims 1-2: Establishment of precedent for biaryl coupling and quinone formation The enantioselective coupling with diaza-cis-decalin copper catalyst (R,R or S,S-15) is a proven method for the oxidative coupling of functionalized 2-naphthols, however, naphthols substituted at the C8 position had not been studied previously. A few years ago the Kozlowski group established precedent for the coupling of a simple naphthol with a methoxy moiety at the C8 position (Scheme 6). Using (R,R)-15, high enantioselectivity (90% ee) and moderate yield (59%) of bisnaphthol (S)-19 was obtained. Scheme 6. Precedent for Biaryl Coupling of C8 Substituted Naphthols

10 mol% (R,R)-15

O2, 40 ºC

59%, 90% ee

OH

CO2Me

CO2Me

OH

OMe

CO2Me

OH

OMe

OMe

N

NH

H

Cu

OH

I

18 (S)-19

I then began to investigate the synthesis of the bisnaphthoquinones. The racemate of 19 was synthesized in three steps from commercially available hydroxy naphthol 20 in 60% yield (Scheme 7). Subsequent deprotection of the 8,8ʼ methoxy substituents lead to formation of tetrol 21 in 49% yield after esterification. Oxidation of 21 with salcomine (23) produced bisnaphthoquinone 22 in moderate yield (55%), with 19% of an unsymmetrical ortho/para-bisnaphthoquinone also forming. Scheme 7. Synthesis of Bisnaphthoquinones Route 1.

CO2H

OH

OH

1. H2SO4, MeOH, reflux; 99%2. Me2SO4, K2CO3, reflux; 70%

3. 10 mol% CuCl(OH)TMEDA, O2, 37 ºC; 87%

CO2Me

OH

OMe

CO2Me

OH

OMe

20 19

CO2Me

OH

OH

CO2Me

OH

OH

1. BBr3, 0 ºC to rt2. H2SO4, MeOH, reflux 10 mol%, O2

55% para/para(19% ortho/para)

OCo

N N

O

CO2Me

OH

O

CO2Me

OH

O

O

O 2221

23

49% tetrol, 2 steps, (27% triol)

Due to the inefficiency (incomplete reaction, hydrolysis, and solubility difficulties) of the demethylation step from 19 to 21 (Scheme 7), a new protecting group (benzyl) was chosen for the C8 phenol (Scheme 8). Starting from 7, esterification and selective benzylation provided naphthol 24 in good yield (72%, 2 steps). The use of CuCl(OH)TMEDA provided the racemate 25 in high yield (91%). When the (R,R) or (S,S)-diaza-cis-decalin copper catalyst (15) was used (S) or (R)-25 were produced, respectively, in moderate yield, but with high selectivity (95-97% ee, Scheme 8). The lower yields could be attributed to increased steric hinderance from the C8 substituent. Subsequent methylation, hydrogenation, and oxidation lead to (R)-26 in good yields, while retaining the enantiomeric excess (Scheme 8).

Preliminary Studies/Progress Report Page 33

Preliminary Studies/Progress Report

Scheme 8. Synthesis of Bisnaphthoquinones Route 2.

CO2H

OH

OH

CO2Me

OH

OBn

CO2Me

OH

OBn

CO2Me

OH

OBn

1. H2SO4, MeOH, reflux; 99%

2. BnBr, K2CO3, reflux; 73%

**(R,R)-catalyst, 2 d; led to formation of (S)-25 in 54% (67% based on recovered starting material), 97% ee

N

N

H

H

Cu I

OH

10 mol% (S,S)-15

40 ºC, O2, 1 d

47%, 95% ee

CO2Me

OMe

O

CO2Me

OMe

O

O

O

1. Me2SO4, NaH; 76-99%2. Pd/C, H2, HCl; 87-99%

3. O2, 20 mol%

57%, 88% ee

OCo

N N

O(R)-252420

(R)-2623

Specific Aim 1: Precedent for regiocontrol of Diels-Alder reaction

After preliminary Diels-Alder reactions with Danishefskyʼs diene showed that a bisanthraquinone could be formed under thermal conditions, control of the regiochemistry of the Diels-Alder reaction via Lewis acid catalysis was examined (Scheme 9). When the Diels-Alder reaction between 26 and 10a was conducted in the presence of two equivalents of ZnCl2, followed by exposure to silica and air, three bisanthraquinone isomers were isolated (Scheme 9). Two of these regioisomers are symmetrical (27 and 29) and the third unsymmetrical (28). When the Diels-Alder reaction between 26 and 10a was conducted in the presence of two equivalents ZnCl2 (Scheme 9) the ratio of isomers observed was 4:3:1 of 27:28:29. However, when four equivalents were used, this ratio shifted towards the desired regioisomer in a ratio of <0.2:1:4.5 of 27:28:29 (Scheme 9).

Scheme 9. Control of Regioselectivity with Zinc Chloride.

Me

OTMS

OMe

OMe

CO2Me

CO2Me

O

OO

O

X equiv ZnCl2, benzene, 0 ºC to rt;

then exposure to silica

OMeOMe

OMe

CO2Me

CO2Me

O

OO

O

OHOH

Me

Me

OMe

OMe

CO2Me

CO2Me

O

OO

O

OH

Me

OH

Me

OMe

OMe

CO2Me

CO2Me

O

OO

O

OH

Me

OH

2

4

4

--

3

1

Equiv ZnCl2

1

4.5

Me

+ +

26 292827

10a

Preliminary Studies/Progress Report Page 34

Preliminary Studies/Progress Report

Research Design and Methods The synthetic transformations proposed in Specific Aims 1 and 2 will all be conducted and optimized first on racemic material before using enantiopure samples. The enantiomeric excess will be determined via chiral high-performance liquid chromatography (HPLC). The initial focus of this research will be the synthesis of the bisanthraquinone natural products. Generation of bisoranjidiol 9 will be explored first, as it required less steps and is structurally less complex than natural products 4-8. Concurrently, the simplest chiral bisanthraquinone BINOL analog could also be synthesized (Specific Aim 1), as the same intermediate is used to generate bisoranjidiol. Once bisoranjidiol has been synthesized, focus will shift to the five other bisanthraquinones. Knowledge gained from the synthesis of bisoranjidiol will prove useful for this route. Once all of the bisanthraquinones have been synthesized, accomplishing the objectives of Specific Aim 2, the focus will be placed on finishing the goals of Specific Aim 1. Specific Aim 1: Synthesis of Chiral Bisnaphthoquinones In preliminary studies, two different bisnaphthoquinones have already been successfully synthesized (Schemes 7, 8). From these versatile substrates, a variety of chiral BINOL analogs can be generated possessing either a disubstituted 3,3ʼ-disubstituted skeleton with sterically influential groups at these positions, or extension through the quinone moiety. The simplest analog is 2a, which lacks functionality at 3,3ʼ. It could be generated from precursor 1 via decarboxylation (Scheme 10). Once this ligand is obtained, the chemical stability and atropisomerism of the molecule will need to be assessed. The effects of acidic, basic, oxidative, reductive, and thermal conditions will be examined via NMR and HPLC. Metal complexes of the bisnaphthoquinone with titanium 30a and zirconium 30b will also be formed and characterized (Scheme 10).

Scheme 10. Generation of Chiral Bisnaphthoquinones and Metal Complexes.

1

1) NaOH2) –CO2

2a

1 2

345

6

78 M(OR)4

O

O

O

O

O

O

M

30a M = Ti b M = Zr

OR

ORM = Ti, Zr

OH

O

OH

O

O

O

CO2Me

OH

O

CO2Me

OH

O

O

O

After this point, the performance of these molecules as ligands will be ascertained by direct comparison with other BINOL analogs possessing electron-withdrawing groups as shown in Scheme 11. Specifically, the yield and enantiometric excess with bisnaphthoquinone 2a as a ligand will be compared to BINOL analogs in three different reported reactions employing zirconium (a, aldol-type reaction),20 titanium (b, 1,3-dipolar cycloaddition),21 and hydrogen bonding catalysts (c, allylboration).22

Scheme 11. Test reactions for Comparison with BINOL Analogs. a) Aldol-type reaction

H

O

OEt

N2

O

OEt

N2

Ph

OH

OH

OH

Br

Br40 mol%

20 mol% Zr(Ot-Bu)4PhCHO

DME, H2O, –35 °C 65%, 87% ee

b) 1,3-Dipolar Cycloaddition c) Allylboration

Ph

N+

O–

CHPh2

MeOHC

ON

Ph

MeOHC

CHPh2

OH

OH

F3C

F3C10 mol%

10 mol% Ti(Oi-Pr)4CH2Cl2, 0 °C

+

84%, 97% ee

Ph

O

Me

(i-PrO)2B

+

OH

OH

Br

Br

Ph

HO Me

83%, 94% ee

15 mol%

PhCH3/PhCF3

–35 °C

Many other BINOL analogs can be generated from bisnaphthoquinone 2. For example, analogs with

sterically influential groups near the metal center such as 2b, or BINOLs extended through the quinone moiety via Diels-Alder reactions (31) or ketalization (33, Scheme 12). Compound 33 could be more hindered than H8-BINOL (32). The utility of these novel ligands would also be compared against BINOL in the same manner.

Research Design and Methods Page 35

Research Design and Methods

Other uses of this type of chiral molecule will also be explored, such as its use together with air as a chiral catalytic oxidant for dearomatization reactions.

Scheme 12. Extended BINOLs.

OH

O

OH

O

O

O

OH

O

OH

O

O

O

[O]

13 2

OH

HO

R

R

OO

O O

O OO O

OH

HO

R

R

OO

O O

O OO O

H2Pd/C

1) Ac2O, Et3N2) H+,

3) NaOH

31 14

OHHO

1)

2)

R R

RR

OH

O

OH

O

O

O 2b

OH

OH

32

Specific Aim 2: Synthesis of Chiral Bisanthraquinones Retrosynthetic analysis of bisanthraquinones 4-9 (Scheme 2) reveals three key synthetic transformations (Scheme 4). These are 1) Diels-Alder/aromatization reaction between a bisnaphthoquinone intermediate and vinylketene acetal, 2) oxidation of a 8,8ʼ-dihydroxy substituted bisnaphthol to selectively form the para-bisnaphthoquinone, and 3) the enantioselective biaryl coupling reaction to form the bisnaphthol. While bisanthraquinones 4-9 (Scheme 2) all share these key steps to their synthesis, there exists two structural differences between bisoranjidiol 9 and the other bisanthraquinones 4-8, requiring different synthetic routes and approaches. These routes will be discussed separately. The first architectural difference is that bisoranjidiol (9) lacks the 4,4ʼ-hydroxy functionality shared by all bisanthraquinones 4-8. The higher degree of functionality required of the coupling precursor for 4-8 would necessitate formation of the naphthol ring system via synthetic means. The desired naphthol for 9, however, can be easily generated from a commercially available naphthol (20, Scheme 8). The second difference is with the left-hand rings of the bisanthraquinones. Compounds 4-8 share substitution at 5,5ʼ and 7,7ʼ, while 9 has an ortho relationship (5,5ʼ and 6,6ʼ). Synthesis of 5,5ʼ-bisoranjidiol The proposed synthesis of bisoranjidiol 9 takes advantage of efforts already made in the synthesis of chiral bisnaphthoquinones, discussed in Specific Aim 1. Specifically the bisanthraquinone framework could be accessed directly from bisnaphthoquinone 26 through a Diels-Alder reaction of diene 11 (Scheme 13). This would be followed by acid formation and decarboxylation to give compound 9. Scheme 13. Synthesis of 5,5ʼ-Bisoranjidiol.

OMe

OMe

CO2Me

CO2Me

O

OO

O

OTMS

lewis acid

OMeMe

(S)-26

11OMe

OMe

CO2Me

CO2Me

O

OO

O 33

OH

Me

OH

Me

1) BCl3

2) NaOH; decarboxylation

9

Synthesis of 4,4ʼ-substituted bisanthraquinones Naphthols, with a hydroxyl at C4, are a necessary intermediate for the synthesis of natural products 4-8 (Scheme 2). This hydroxyl could be generated from the appropriate phenylacetic acid through a four step sequence. Functional group tolerance is limited for this sequence. A benzyl protected phenol, which coincides with a benzyloxy group at the C8 position of the resulting naphthol is not stable to these conditions. A methoxy group is stable, however, due to the potential difficulties of deprotection of the 8,8ʼ phenols of the biaryl species as was experienced with 19 (Scheme 7), this route was not pursued further. Halogens are stable to the cyclization conditions and 2-chlorophenylacetic acid (34) could be used as a starting point (Scheme 14). Once the bisacetate compound 35 has been successfully synthesized, a selective deprotection of the 2-hydroxyl with base generates the desired coupling precursor. Enantioselective naphthol coupling would give the biaryl



system 37. After protection of the 2,2ʼ- and 4,4ʼ-hydroxyls as methyl ethers, a Buchwald-Hartwig palladium catalyzed cross-coupling could be used to directly install the oxygen functionality at 8,8ʼ.23, 24 Salcomine oxidation should proceed similarly as with 26, likely forming both the desired para/para-bisnaphthoquinone and the ortho/para-bisnaphthoquinone. From this versatile intermediate 40, reaction with the desired ketene acetal should give the bisanthraquinone. Subsequent protecting group manipulations followed by either reduction of the ester groups to methyls or conversion to acids and decarboxylation would quickly provide five natural products. If regioselection is modest for the Diels-Alder reaction, another means of controlling the regioselectivity is via an “internal Lewis Acid,” namely, H-bonding between the 4,4ʼ-hydroxyl and the 5,5ʼ-carbonyls effectively act as Lewis Acids (43, Scheme 15). Due to inherent difficulties of conducting two Diels-Alder/aromatization reactions on the same molecule, optimization of yield, and Lewis acid employed for control of regioselection will be conducted on a model system (Scheme 16). This also easily allows for comparison of substrates containing unprotected phenols (44a) with their fully protected counterparts (44b). Scheme 14. Synthesis of Highly Functionalized Naphthols.

Cl

OH

O

Cl

CO2Me

OAc

OAc

1. SOCl2, reflux 2. (MeO2C)2CHNa

3. CH3SO3H, P2O5 or H2SO4

4. Ac2O, pyridineCl

CO2Me

OAc

OH

K2CO3, CH2Cl20 ºC Cl

CO2Me

OAc

OH

Cl

CO2Me

OAc

OH

(R, R)-cat, O2

Cl

CO2Me

OMe

OMe

Cl

CO2Me

OMe

OMe

MeI, NaHwet DMF OH

CO2Me

OMe

OMe

OH

CO2Me

OMe

OMe

KOH, 20 mol% Pd2dba3, x-phos(t-Bu) heat O

CO2Me

OMe

OMe

O

CO2Me

OMe

OMe

salcomine, O2

O

O

R1

OMe

OTMS

L.A.

R1 = Me, OMe, H

OMe

OMe

OH

OH

R1

R1

OMe

OMe

CO2Me

CO2Me

O

OO

O

OR3

OR3

OH

OH

R1

R1

OH

OH

CO2Me

CO2Me

O

OO

O




5 R1 = OMe, R2 = Me, R3= H

6 R1 = R2 = R3 = H

OR3

OR3

OH

OH

R1

R1

OH

OH

R2

R2

O

OO

O

BCl3

DIBAL;

NaCNBH3

(R2 = Me)

OR

NaOH;

decarboxylation

(R2 = H)

34 35 36 37

403938

4241

10

Scheme 15. “Internal Lewis Acid.”

O

CO2Me

O

OMe

O

CO2Me

O

OMe

O

O

43

H

H

4

4'

5

5'



Scheme 16. Model system for Diels-Alder reaction

O

CO2Me

OH

O

45

O

CO2Me

OMe

O

OR

R

OMe

OTMS

O

CO2Me

OMe

O

R

OH

Lewis acid

44b

44a

Summary This project will result in total synthesis of a group of natural products that has not been synthesized previously, resulting in material for biological study. This aspect of the project is expected to take 1.5 years. In addition, a new class of BINOL-type chiral ligands will be generated. Examination of the many possibilities of these compounds will be the focus of the remainder of the fellowship period.



Respective Contributions

The research training plan submitted for this application was written solely by myself (the applicant) then reviewed by my sponsor for editing purposes and suggestions. While the core idea behind this plan was not original, I have modified and expanded the plan to its present form. This was accomplished following results and observations from the preliminary research that I have already conducted. These modifications were both original as well as the result of discussions and suggestions received during our weekly group meetings. To illustrate this, I for example, have extended the projectʼs natural product targets to include 5-5ʼ-bisoranjidiol, I have modified the route for accessing the five complex bisanthraquinone natural products to include a palladium catalyzed coupling reaction, proposed an alternate and shorter route for accessing the bisnaphthoquinones (incorporation of a C8 benzyl protected naphthol). I expect to accomplish the proposed research independently while under the supervision of my sponsor. My sponsor will provide guidance and suggestions for the research.

Respective Contributions Page 39

Respective Contributions

Selection of Sponsor and Institution I chose the University of Pennsylvania for my graduate education because the chemistry department has a very good reputation. In particular the chemistry department has a very good program for training in organic synthesis. This is what Iʼm interested in. Besides its respected reputation, which can play an influential factor in my career, I thought the University of Pennsylvania (Penn) offered more diverse and interesting opportunities in chemical research than any of the other institutions I had considered. As such, there were several professors at Penn I was interested in working for. In making my decision, I established a set of criteria for my education and research training. These goals are as follows:

1. As I am very interested in organic synthesis, I wanted a group that was interested in some synthetic projects. 2. I have always held an interest in the interface between chemistry and biology. I wanted to have an opportunity to work on a project with this multidisciplinary aspect, while still maintaining my focus in organic chemistry. I was interested in this because the research could have the potential to impact medicine and public health through therapeutics or otherwise. 3. I also wanted the opportunity to diversify and gain perspective in areas other than just total synthesis, such as methodology or biological studies.

These goals were a major factor in my decision to choose Dr. Marisa Kozlowski as my dissertation advisor and sponsor for this application. I feel she is my best opportunity to accomplish these goals and those specific aims outlined in the research training plan. To briefly illustrate, the research in her group is quite diversified with much of it focused on the development of new methods. These methods are then applied to the synthesis of natural products and derivatives with interesting biomedical implications. Upon completion of the synthesis, analysis was taken one step further to biological testing. A good example of this is the perylenequinone natural products. Using our methodology these molecules were synthesized by our group and the inhibitory effects on protein kinase C (PKC) were also assessed.

Selection of Sponsor and Institution Page 40

Selection of Sponsor and Institution

Responsible Conduct of Research

Upon entering graduate school, instruction was received in the Responsible Conduct of Research during orientation week. A student handbook on ethics and original research was given to all graduate students, and the contents of which were discussed. Topics included academic integrity, plagiarism, paraphrasing, proper citation of sources, etc. Also, as part of our Chemical Information course taken the second semester of our first year, we discussed several ethics case studies taken from On Being a Scientist: Responsible Conduct in Research, Washington, DC: National Academy Press, 1995. As a course requirement, we also completed several online bioethics training modules provided on the website of the Vice Provost for Research at the University of Pennsylvania. Topics included keeping a laboratory notebook (ownership of data and intellectual property), authorship, collaborative science, misconduct in science (including Pennʼs procedures regarding misconduct), conflicts of interest, and peer review materials. These modules involved presentations/lectures and quizzes. They were also discussed in class. If this is found to be unacceptable for NIH staff, then further electronic training in the Responsible Conduct of Research will be pursued. The University of Pennsylvania maintains an online website where training can be received in these areas: - Data acquisition, management, sharing, and ownership - Materials, their ownership, and material transfer agreements - Intellectual property, copyrights, patents, licenses, and technology transfer - Authorship and publication practices - Peer review - Mentor/trainee responsibilities, and collaborative science - Human subjects - Research involving animals - Environmental safety: radiation, chemicals, and microbial agents - Research misconduct - Conflict of interest - Preparing grant proposals - Research administration: financial and personnel management “Each rubric includes Penn policies, lectures, guidelines, interactive quizzes, Federal policies, and hyperlinks to a few selected websites at other institutions. In the aggregate, these materials provide a systematic introduction to the fundamental issues underlying the Responsible Conduct of Research. Many Penn programs supplement these materials with small group discussions of the subjects listed above. Finally, each School or Department maintains a database that can be used to track all trainees and insure that each of them has completed an appropriate discipline-specific Responsible Conduct of Research instruction and certification program."

Responsible Conduct and Research Page 41

Responsible Conduct and Research

Goals for Fellowship Training and Career Beyond graduate school I plan to take a postdoctoral position at another university before pursuing a career in academia. One reason why Iʼm aspiring to work in academia is that I see it as an opportunity to encourage diversity and broaden the opportunities of persons with disabilities in science by serving as a role model for others that may be facing challenge

and I would be in a position to teach them. Over the past few years of undergraduate and graduate school I have been a tutor for organic chemistry and calculus II, a teaching assistant for an undergraduate organic chemistry laboratory for two years, as well as a mentor for an REU student (research experience for undergraduates) from Puerto Rico. I enjoy working with and helping students learn. As an academic, not only would I have the opportunity to teach students from a classroom environment but also from a research standpoint, like the position I was in with the REU student. Due to the synthetic nature and possible health implications of the proposed research training, this will enable hands-on experience with a variety of chemical transformations and a broader background that would not necessarily be attained with methods-based or mechanistic research. I think a broader background is important for a career in academia as in enables you to personally relate your experiences and guide students with interests in different areas of chemistry, its interface with biology, and their role in improving public wellbeing.

Goals for Fellowship Training and Career Page 42

Goals for Fellowship Training and Career

Activities Planned Under This Award All course work and teaching requirements of the chemistry PhD program at the University of Pennsylvania have been fulfilled during my first year of graduate study. Also, all cumulative examinations have been successfully completed. Therefore under this award, time will be allocated as follows: Year one: 100% research Year two: 100% research Year three: 100% research

Activities Planned under this Award Page 43

Activities Planned under this Award

Research Experience

My research experience has covered a variety of disciplines in chemistry from crystal engineering and metal directed self-assembly as an undergraduate to organic synthesis as a graduate student at the University of Pennsylvania. These research experiences are included below in chronological order.

University of Virginia, Undergraduate Research 2006. In the summer of 2006 I participated in a

Chemistry REU program (Research Experience for Undergraduates) at the University of Virginia. During my ten week tenure, I worked for Dr. Michal Sabat in his molecular structures laboratory where I investigated the crystal engineering of propargylic alcohols. Our goal was to form higher order supramolecular systems in the solid-state that are able to entrap gas or solvent molecules; specifically we were interested in trapping and storing hydrogen gas because more effective hydrogen gas storage would improve the practicality of using environmentally friendly hydrogen gas fueled vehicles; an outcome that would broadly benefit society. The chiral propargylic alcohol 1 has been shown to form cyclic RSRSRS hexameric assemblies in the solid-state (Figure 1a). These assemblies are stabilized by a network of hydrogen bonds and π-π stacking interactions and contain pores and channels that trap solvent molecules.1 My role in the project was to use crystallization and co-crystallization techniques to form novel highly ordered systems that could be tested for gas adsorption. All crystallization experiments were run independently, resulting in a few crystal structures. Collaboration with other researchers was necessary to obtain crystal structures and synthesize compounds.

Another aspect of my project focused on propargylic alcohols containing long alkyl side chains, such as 2 (Figure 1b). These derivatives may be used as gelators and may have applications in chiral discrimination, controlled flow of drugs, etc. For these compounds, I tried to grow single crystals for X-ray diffraction analysis and also used diffusion ordered NMR spectroscopy (DOSY-NMR) to measure diffusion rates for the study of aggregation in solution. Also, various properties, such as distance external to the surface (de; Figure 1c), shape index, and curvedness were plotted on a Hirshfeld surface.2 I learned to identify characteristic features of these plots and the two-dimensional fingerprint plots which are derived from the Hirshfeld surface.2,3

Gettysburg College, Undergraduate Research 2006-2007. During my senior year at Gettysburg College I utilized a face-directed approach to metal-directed self-assembly of metallocage coordination complexes. Specifically, I was interested in the formation of coordination complexes possessing a cubic architecture by using “naked” square-planar metals and carbazole based dipyridine ligands. Carbazole offers several advantages for use as a constructional subunit, as its photochemical behavior might confer unique properties onto the complex that could be studied and it serves as a platform for generating bidentate “corner” elements where any substituents attached to C3/C6 are oriented at a 90° angle. Ideally when the appropriate metal ion and ligand, possessing a rigid predefined geometry, are combined stoichiometrically the desired architecture will form. This requires metal-ligand bonds that are labile enough to allow for self-correction of “mistakes” as enthalpy and entropy drive the reaction forward. Ligands 6a and 6b were each synthesized via Suzuki coupling reactions (Scheme 1) and combined stoichiometrically with “naked” palladium(II) to form discrete coordination complexes in solution. These are likely cubic cages with metal ions occupying the faces and right-angle ligands spanning the edges of the cube (7). Complex

OH FF

FF

F

OH FF

FF

F

1 2

a) c)b)

Plot of de on the Hirshfeld surface

Figure 1.

HN RN

N

N

RN

I

I

1. R-X, NaOH 2. I2 / KIO3, HOAc

6a: R = n-Bu (26%) b: R = (CH2CH2O)2CH3 (47%)

Pd(PCy3)2Cl2, aq K3PO4, 100° C

= Pd(II)

= 6a or 6b 4a: R = n-Bu (91%, 2 steps) b: R = (CH2CH2O)2CH3 (73%, 2 steps)

0.5 equivPd(NO3)2-2H2O,

DMSO-d6, 90-95° C

N B

OH

OH

7

3

5

Scheme 1.

3

6

Doctoral Dissertation and Other Research Experience Page 44

Doctoral Dissertation and Other Research Experience

formation was demonstrated in solution (DMSO-d6) via 1H NMR. Evidence for complexation included the presence of a single species with high symmetry, as would be expected for the formation of cubic cages, downfield shifting of the α-py and β-py protons (Δδα-py= 0.75 and Δδβ-py= 0.50), indicative of complexation with the metal ion, and moderately broad peaks suggesting that a large supramolecular complex had formed. The self-assembly of discrete two- and three-dimensional complexes, such as cage 7, is significant to host-guest chemistry and materials science. These complexes have applications in reaction catalysis, chiral resolution, molecular recognition and guest binding/encapsulation, which is beneficial as it may, for example, inspire development of new chemical sensors, switches, or gas storage materials. University of Pennsylvania, Graduate Research 2008-present. At the University of Pennsylvania, I have been synthesizing axially chiral bisnaphthoquinones, which are potentially useful BINOL derivatives (8) for asymmetric catalysis with possible redox properties. The chiral bisnaphthoquinones are also versatile intermediates for accessing the bisanthraquinone natural products, such as those shown in Figure 2 (9-13). No stereoselective syntheses have been reported and an efficient synthesis of these biaryls would be beneficial as skyrin (9), for example, has been shown to suppress growth of tumor cell lines.4

Much of the research thus far has been carried out on a simpler system, without substitution on C4 (Scheme 2). This simpler system serves as both a model for the bisanthraquinones 9-13, as well as the means for generating unique BINOL analogs. Working with racemic substrates initially, compound 15a can be synthesized in only three steps. Ideally, deprotection of the methyl ether groups followed by oxidation would produce the desired bisnaphthoquinone intermediate. While oxidation to the bis-para-quinone can be achieved in moderate yield (56%), the preceding deprotection of 15a was found to be inefficient. As such, a different C8 protecting group (benzyl group) was chosen. Enantioselective oxidative coupling of this new substrate with 19 is very promising, generating (S)-15b in 97% ee. With CuCl(OH)TMEDA, coupling to form racemic 15b also proceeded well (91% yield). Methylation of the C2 phenols, removal of the benzyl groups via hydrogenation and subsequent oxidation with salcomine formed the bis-para-naphthoquinone 16. A regioselective Diels-Alder reaction with diene 17 and subsequent oxidation produces bisanthraquinone 18.

OH

OH

O

OH

OH

OMe

O

OR

OH

OMe

O

OR

OMe

OMe

O

O

OMe

OMe

O

O

O

O

OMe

O

OMe

O

O

OOH

OH

Me

Me

1. H2SO4, MeOH, 99%

2. (15a) Me2SO4, K2CO3; 70%

(15b) BnBr, K2CO3, 73%

3. CuCl(OH)TMEDA,

O2, (15a) 87%; (15b) 91%

N

N

H

H

Cu I

OH

(S,S)

1. NaH, Me2SO4;

76-99% 2. Pd/C, H2, HCl;

87-99%

3. 20 mol%

salcomine, O2;

57%

O

OMeOMe

OTMS

Me

14 15a: R = Me b: R = Bn

16

17

1819

1

2

345

6

78

O

ZnCl2

OMe

Scheme 2.

1 Hyacinth, M., Chruszcz, M., Lee, K. S., Sabat, M., et. al. Angew. Chem. Int. Ed., 2006, 45, 1. 2 McKinnon, J. J., Spackman, M. A., Mitchell, A. S., Acta Cryst., 2004, B60, 627-668. 3 Spackman, M. A., McKinnon, J. J., Cryst. Eng. Comm., 2002, 4, 378-392. 4 Lin, L. C.; Chou, C.; Kuo, Y. "Cytotoxic Principles from Ventilago Leiocarpa" J. Nat. Prod. 2001, 64, 674-676.




12 R1 = OMe, R2 = Me, R3= H

13 R1 = R2 = R3 = H

OR3

OR3

OH

OH

R1

R1

OH

OH

R2

R2

O

OO

O

43

2

1

5

6

78

R4

OH

O

OH

O

O

O

8

R4

Figure 2.

Doctoral Dissertation and Other Research Experience Page 45

Doctoral Dissertation and Other Research Experience

Podlesny, Erin Eileen Title: Synthesis of Bisanthraquinone ... › gms › files › 2015 › 12 ›...

Documents

Transcript of Podlesny, Erin Eileen Title: Synthesis of Bisanthraquinone ... › gms › files › 2015 › 12 ›...